These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32472706)

  • 21. Enhancement of resistance and suppression of immunization against experimental Trypanosoma cruzi infection by Corynebacterium parvum.
    Kierszenbaum F
    Infect Immun; 1975 Nov; 12(5):1227-9. PubMed ID: 811568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of interferon, antibodies and macrophages in the protective effect of Corynebacterium parvum on encephalomyocarditis virus-induced disease in mice.
    Géniteau-Legendre M; Forestier F; Quéro AM; German A
    Antiviral Res; 1987 Mar; 7(3):161-7. PubMed ID: 2440381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunity to transplantable nitrosourea-induced neurogenic tumors. I. Potentiation of tumor immunity with Corynebacterium parvum.
    Cravioto HM; DeBernardo E; Hochwald GM; Thorbecke JG
    J Neuropathol Exp Neurol; 1981 Sep; 40(5):526-36. PubMed ID: 7276992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
    Fisher B; Wolmark N; Coyle J
    J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
    [No Abstract]   [Full Text] [Related]  

  • 25. Antitumor activity of Corynebacterium parvum.
    Milas L; Scott MT
    Adv Cancer Res; 1978; 26():257-306. PubMed ID: 343523
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corynebacterium parvum: immunomodulation in local bacterial infections.
    Calhoun K; Trachtenberg L; Hart K; Polk HC
    Surgery; 1980 Jan; 87(1):52-8. PubMed ID: 6985758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TNIP1 Regulates
    Erdei L; Bolla BS; Bozó R; Tax G; Urbán E; Kemény L; Szabó K
    Front Immunol; 2018; 9():2155. PubMed ID: 30319618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitogenicity of Corynebacterium parvum for mouse lymphocytes.
    Zola H
    Clin Exp Immunol; 1975 Dec; 22(3):514-21. PubMed ID: 817854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of Corynebacterium parvum and Corynebacterium liquefaciens on antitumor activity against sarcoma-180.
    Ideda H; Yamagata S; Toge T; Hattori T
    Gan; 1977 Apr; 68(2):233-5. PubMed ID: 892298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-cell Corynebacterium parvum generated by nanotechnology: a promising immunomodulator with less side effects.
    Gao S; Liu C; Qu S; Song J; Li J; Zhang P; Wang Q; Guo C; Gao F; Zhang L
    Int Immunopharmacol; 2007 Oct; 7(10):1334-42. PubMed ID: 17673148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of Corynebacterium parvum during remission maintenance therapy in pediatric patients with acute lymphoblastic leukemia.
    Lankford J; Nitschke R; Wells J; Cox C; Humphrey GB
    Med Pediatr Oncol; 1979; 6(2):101-14. PubMed ID: 287855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corynebacterium parvum prevents immunization to admixed irradiated tumor cells by a local process.
    Titus MJ; Bartlett GL; Kreider JW
    Int J Cancer; 1982 Jun; 29(6):699-705. PubMed ID: 7107070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mechanism of the antitumor immunity potentiated by anaerobic Corynebacterium parvum].
    Miyata H
    Fukuoka Igaku Zasshi; 1983 Jul; 74(7):451-69. PubMed ID: 6662469
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.
    Dye ES; North RJ; Mills CD
    J Exp Med; 1981 Sep; 154(3):609-20. PubMed ID: 6974214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumour effects of Corynebacterium parvum in mice.
    Castro JE
    Eur J Cancer (1965); 1974 Feb; 10(2):121-7. PubMed ID: 4435007
    [No Abstract]   [Full Text] [Related]  

  • 38. Corynebacterium parvum as an immunotherapeutic anticancer agent.
    Scott MT
    Semin Oncol; 1974 Dec; 1(4):367-78. PubMed ID: 4620441
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice.
    Scott MT
    J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of mice against influenza virus infection: enhancement of nonspecific cellular responses by Corynebacterium parvum.
    Mak NK; Schiltknecht E; Ada GL
    Cell Immunol; 1983 Jun; 78(2):314-25. PubMed ID: 6861206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.